يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Renwick, William E. P."', وقت الاستعلام: 0.42s تنقيح النتائج
  1. 1
    Periodical
    Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)

    المؤلفون: Quach, Hang, Lasica, Masa, Low, Michael, Mollee, Peter, Lai, Hock Choong, Wong Doo, Nicole, Hocking, Jay, Campbell, Philip, Murphy, Nicholas E., Sidiqi, M Hasib, Routledge, David, Heenan, Jessica, Horvath, Noemi, Eek, Richard, Renwick, William E. P., Lenton, Douglas Stuart, Child, Lauren J, McCaughan, Georgia, Butcher, Belinda E, Mazumdar, Deepmala, Kalff, Anna

    المصدر: Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p2023-2023, 1p

    Full Text Finder

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Endobronchial ultrasound-guided transbronchial needle aspiration for the evaluation of suspected lymphoma.

    المؤلفون: Steinfort, Daniel P., Conron, Matthew, Tsui, Alpha, Pasricha, Sant-Rayn, Renwick, William E. P., Antippa, Phillip, Irving, Louis B.

    المصدر: Journal of Thoracic Oncology; Jun2010, Vol. 5 Issue 6, p804-809, 6p

    Full Text Finder

    أضف إلى المفضلة
  3. 3
    Periodical
    Early Monoclonal Para Protein Reduction and Response in Multiple Myeloma (EMPEROR study)

    المؤلفون: Panigrahi, Ashish Kumar, Renwick, William E. P., Carradice, Duncan P., Lim, Andrew, Hatzis, Eleni

    المصدر: Blood; December 2016, Vol. 128 Issue: 22 p5707-5707, 1p

    Full Text Finder

    أضف إلى المفضلة
  4. 4
    Periodical
    Quality of Life in Fit Elderly Patients with Chronic Lymphocytic Leukemia (CLL) Receiving Oral Fludarabine-Based Regimens As First Line Therapy: Australasian Leukaemia and Lymphoma Group (ALLG) CLL5 Trial

    المؤلفون: Sandhu, Suneet, Gill, Devinder, Turner, Paul David, Renwick, William E. P., Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David R, Campbell, Philip, Forsyth, Cecily, Cull, Gavin, Harrup, Rosemary, Best, Giles, Bressel, Mathias, Di Iulio, Juliana, Kuss, Bryone Jean, Mulligan, Stephen

    المصدر: Blood; December 2015, Vol. 126 Issue: 23 p5295-5295, 1p

    Full Text Finder

    أضف إلى المفضلة
  5. 5
    Periodical
    Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

    المؤلفون: Mulligan, Stephen P., Gill, Devinder, Turner, Paul, Renwick, William E. P., Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David R, Campbell, Philip, Forsyth, Cecily J, Cull, Gavin, Harrup, Rosemary, Sulda, Melanie, Best, Giles, Bressel, Mathias, Di Iulio, Juliana, Kuss, Bryone J

    المصدر: Blood; December 2014, Vol. 124 Issue: 21 p4695-4695, 1p

    Full Text Finder

    أضف إلى المفضلة
  6. 6
    Periodical
    A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity

    المؤلفون: Mulligan, Stephen P., Gill, Devinder, Turner, Paul, Renwick, William E. P., Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David, Campbell, Philip, Forsyth, Cecily J, Cull, Gavin, Harrup, Rosemary, Sulda, Melanie, Best, Giles, Bressel, Mathias, Di Iulio, Juliana, Kuss, Bryone J

    المصدر: Blood; December 2014, Vol. 124 Issue: 21 p3325-3325, 1p

    Full Text Finder

    أضف إلى المفضلة
  7. 7
    Periodical
    A Randomised Dose De-Escalation Safety Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – End of Recruitment Analysis of Response and Toxicity of the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study

    المؤلفون: Mulligan, Stephen P, Gill, Devinder S, Turner, Paul, Renwick, William E. P., Harrup, Rosemary, Latimer, Maya, Mackinlay, Naomi, Berkahn, Leanne, Simpson, David, Campbell, Philip, Tiley, Campbell, Cull, Gavin, Collins, Marnie, Cortissos, Paul, Sulda, Melanie, Best, Giles, Kuss, Bryone J

    المصدر: Blood; November 2012, Vol. 120 Issue: 21 p436-436, 1p

    Full Text Finder

    أضف إلى المفضلة
  8. 8
    Periodical
    The Safety and Tolerability of Oral Fludarabine, ±oral Cyclophosphamide and Iv Rituximab Therapy In Previously Untreated Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – Interim Analysis From the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study.

    المؤلفون: Mulligan, Stephen P, Gill, Devinder S, Renwick, William E. P., Sulda, Melanie L, Best, O. Giles, Kuss, Bryone J, Seymour, John F

    المصدر: Blood; November 2010, Vol. 116 Issue: 21 p699-699, 1p

    Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء